Comparison of Sedation Efficacy Between Remifentanil and Dexmedetomidine in Arteriovenous Fistula Placement Surgery

Document Type : Original Article

Authors

1 Hasheminejad Hospital, Iran University of Medical Sciences (IUMS), Tehran, IR Iran.

2 Firoozgar General Hospital, Iran University of Medical Sciences (IUMS), Tehran, IR Iran.

3 Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, IR Iran.

4 Cardiac Rehabilitation Department, Rajaie Cardiovascular Medical and Research Center, Tehran, IR Iran.

5 Rajaie Cardiovascular Medical and Research Center, Iran university of medical sciences (IUMS), Tehran, IR Iran.

Abstract

Background: Arteriovenous fistula (AVF) placement is a surgical procedure performed under local anesthesia and often without the need for muscle relaxants in patients with end-stage renal disease. The results of studies comparing remifentanil (REM) and dexmedetomidine (DEX) in patients undergoing AVF placement are controversial. The present study compared sedation efficacy between REM and DEX in patients undergoing AVF placement.
Methods: The present double-blind randomized clinical trial enrolled 40 patients in the operating room of Shahid Hashemi-Nejad Hospital in 2 groups and compared sedation between REM and DEX at different times during and after the surgery using a visual analog scale and the Ramsay score. The data were recorded and analyzed using SPSS, version 22.
Results: The average pain score 120 minutes after the surgery was 4.9±0.72 and 4.3±0.80 in the DEX and REM groups, respectively (P=0.017). No significant difference was observed in the level of sedation between the 2 groups (P=0.113). The prevalence of tachycardia and bradycardia in the 2 groups was 10% (P=1.00) and 15% (P=1.00), respectively, and no significant difference was observed.
Conclusions: We found no significant differences between DEX and REM concerning sedation efficacy. Further studies with larger sample sizes in each group of patients and different procedural scenarios are recommended. (Iranian Heart Journal 2023; 24(2): 84-93)

Keywords

References

  1. Lawson JH, Niklason LE, Roy-Chaudhury P. Challenges and novel therapies for vascular access in hemodialysis. Nature Reviews Nephrology. 2020; 16(10):586-602.
  2. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. 2015; 385(9981):1975-82.
  3. Cimen SG, Oğuz E, Gundogmus AG, Cimen S, Sandikci F, Ayli MD. Listening to music during arteriovenous fistula surgery alleviates anxiety: A randomized single-blind clinical trial. World journal of transplantation. 2020; 10(4):79.
  4. Shaheen FA, Al-Attar B, Ahmad MK, Follero PM. The burden of disease: Prevalence and incidence of endstage renal disease in Middle Eastern countries. Clinical nephrology. 2019; 93(1):120
  5. Enzler M, Rajmon T, Lachat M, Largiadèr F. Long-term function of vascular access for hemodialysis. Clinical transplantation. 1996; 10(6 Pt 1):511-5.
  6. Vajdič Trampuž B, Arnol M, Gubenšek J, Ponikvar R, Buturović Ponikvar J. A national cohort study on hemodialysis arteriovenous fistulas after kidney transplantation-long-term patency, use, and complications. BMC nephrology. 2021; 22(1):1-9.
  7. Huncke TK, Adelman M, Jacobowitz G, Maldonado T, Bekker A. A prospective, randomized, placebo-controlled study evaluating the efficacy of dexmedetomidine for sedation during vascular procedures. Vascular and endovascular surgery. 2010; 44(4):257-61.
  8. Kim HT, Lee KH, Song JW, Lee KC, Kim HY, Kim MN, et al. Satisfaction in patients with chronic renal failure during the surgical creation of an arteriovenous fistula under monitored anesthesia care using remifentanil. Anesthesia and Pain Medicine. 2013; 8(3):166-70.
  9. Cortinez LI, Hsu Y-W, Sum-Ping ST, Young C, Keifer JC, MacLeod D, et al. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. The Journal of the American Society of Anesthesiologists. 2004; 101(5):1077-83.
  10. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of 2 clinical trials of postoperative pain. The Journal of pain. 2003; 4(7):407-14.
  11. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. 2011.
  12. Myles P, Myles D, Galagher W, Boyd D, Chew C, MacDonald N, et al. Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. BJA: British Journal of Anaesthesia. 2017; 118(3):424-9.
  13. Gazi M, Abitağaoğlu S, Turan G, Köksal C, Akgün FN, Arı DE. Evaluation of the effects of dexmedetomidine and remifentanil on pain with the analgesia nociception index in the perioperative period in hysteroscopies under general anesthesia: A randomized prospective study. Saudi medical journal. 2018; 39(10):1017.
  14. St-Pierre P, Tanoubi I, Verdonck O, Fortier L-P, Richebé P, Côté I, et al. Dexmedetomidine versus remifentanil for monitored anesthesia care during endobronchial ultrasound-guided transbronchial needle aspiration: a randomized controlled trial. Anesthesia & Analgesia. 2019; 128(1):98-106.
  15. Choi JW, Joo J-D, Kim D-W, In J-H, Kwon S-Y, Seo K, et al. Comparison of an intraoperative infusion of dexmedetomidine, fentanyl, and remifentanil on perioperative hemodynamics, sedation quality, and postoperative pain control. Journal of Korean medical science. 2016; 31(9):1485-90.
  16. Kim H, Min KT, Lee JR, Ha SH, Lee WK, Seo JH, et al. Comparison of dexmedetomidine and remifentanil on airway reflex and hemodynamic changes during recovery after craniotomy. Yonsei medical journal. 2016; 57(4):980-6.
  17. Hyung Tae Kim, et al：AVF under MAC using remifentanil. Anesth Pain Med 2013; 8: 166-170
  18. Eun Jin Ahn, Hyo Jin Kim, Hye Ran Choi, Kyung Woo Kim, Byung Mo Lee, Yeo Goo Chang, Si Ra Bang. Ultrasound-guided femoral nerve block for patients undergoing femoral AV fistula. Rewal Medical Journal: 43(4), 2018
  19. Grape S, Kirkham K, Frauenknecht J, Albrecht E. Intra‐operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta‐analysis with trial sequential analysis. Anaesthesia. 2019; 74(6):793-800.
  20. St-Pierre P, Tanoubi I, Verdonck O, Fortier L-P, Richebé P, Côté I, et al. Dexmedetomidine versus remifentanil for monitored anesthesia care during endobronchial ultrasound-guided transbronchial needle aspiration: a randomized controlled trial. Anesthesia & Analgesia. 2019; 128(1):98-106.
  21. Menshawi, M.A., Fahim, H.M. Dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries. Ain-Shams J Anesthesiol 13, 55 (2021). https://doi.org/10.1186/s42077-021-00171-5
  22. Choi JW, Joo J-D, Kim D-W, In J-H, Kwon S-Y, Seo K, et al. Comparison of an intraoperative infusion of dexmedetomidine, fentanyl, and remifentanil on perioperative hemodynamics, sedation quality, and postoperative pain control. Journal of Korean medical science. 2016; 31(9):1485-90.
  23. Kim H, Min KT, Lee JR, Ha SH, Lee WK, Seo JH, et al. Comparison of dexmedetomidine and remifentanil on airway reflex and hemodynamic changes during recovery after craniotomy. Yonsei medical journal. 2016; 57(4):980-6.
Iranian Heart Journal
Volume 24, Issue 2
April 2023
Pages 84-93

Files

Share

How to cite

Statistics